See also this year's filing and all EDGAR filings for this company.
PDF Report 0001583107_2023_Theravance_Biopharma_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001583107, Theravance Biopharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 353,464,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 11,875,000 |
| 3 | remainder_Assets | 242,061,000 |
| 4 | LiabilitiesCurrent | 28,715,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 67,073,000 |
| 9 | ResearchAndDevelopmentExpense | 63,392,000 |
| 10 | remainder_Expenses | 19,216,000 |
| 11 | remainder_Revenues | 51,346,000 |
| 12 | remainder_NetIncome | 970,467,000 |
| 13 | remainder_ComprehensiveNetIncome | -15,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 607,400,000 |
| 1 | Liabilities | 28,715,000 |
| 2 | Expenses | 149,681,000 |
| 3 | Revenues | 51,346,000 |
| 4 | StockholdersEquity | 578,685,000 |
| 5 | NetIncome | 872,132,000 |
| 6 | ComprehensiveNetIncome | 872,124,500 |
| 7 | BaseVar | 903,812,000 |
| 8 | EconomicCapitalRatio | 5.87 |
Edgar->Model Mapping
Feature Distribution
Change over Time
